New therapeutic approaches

S. B. Hanauer*, M. I. Schulman

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Clinicians have witnessed an evolution from sulfasalazine and hydrocortisone to alternative aminosalicylates and steroids. Revolutionary changes beyond these, however, and other 'nonspecific' anti-immunoinflammatory compounds require clarification of the primary events either activating inflammatory cascades or preventing the down-regulation of homeopathic inflammation. The authors remain encouraged by advances in basic research pertaining to IBD and optimistic that novel empiric observations and therapeutic trials will focus bench-side investigation as clinicians strive to improve the quality of life for patients.

Original languageEnglish (US)
Pages (from-to)523-540
Number of pages18
JournalGastroenterology Clinics of North America
Volume24
Issue number3
StatePublished - Sep 26 1995

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'New therapeutic approaches'. Together they form a unique fingerprint.

Cite this